Focusing on SAEs, our patients in treatment with TCZ, ADA, IFX, and ETN experienced serious neutropenia mostly associated with lymphocytosis as anti-TNFα drugs cause a dysregulation of TNFα ligands, including T cells. This evidence concerns the gene ADA and neutropenia.